Central Nervous System Therapeutic Market Revenue 2025 to 2034
Central Nervous System Therapeutic Market Revenue 2025 to 2034
Central Nervous System Therapeutic Market (By Disease: Neurovascular Diseases, Mental Health, Neurodegenerative Diseases, CNS Trauma, CNS Cancer, Infectious Diseases, and Others; By Region: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 127.29 Bn
Forecast Year, 2034
USD 285.72 Bn
CAGR, 2025 - 2034
8.64%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The central nervous system therapeutics market is set for strong expansion, rising from USD 127.29 billion in 2025 to USD 285.72 billion by 2034, driven by advances in neurology treatments and increasing prevalence of CNS disorders.
Central Nervous System Therapeutic Market Size Analysis
Central Nervous System Therapeutic Market Size By Disease 2025 to 2034 (USD Billion)
| Disease | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Neurovascular Diseases | 22.91 | 24.59 | 26.39 | 28.31 | 30.38 | 32.59 | 34.95 | 37.48 | 40.19 | 43.08 |
| Mental Health | 25.46 | 27.77 | 30.29 | 33.03 | 36.03 | 39.29 | 42.86 | 46.74 | 50.97 | 55.58 |
| Neurodegenerative Diseases | 28.00 | 30.88 | 34.04 | 37.51 | 41.33 | 45.52 | 50.14 | 55.20 | 60.77 | 66.89 |
| CNS Trauma | 10.18 | 10.98 | 11.84 | 12.77 | 13.78 | 14.86 | 16.02 | 17.27 | 18.62 | 20.08 |
| CNS Cancer | 15.27 | 16.79 | 18.44 | 20.26 | 22.25 | 24.44 | 26.84 | 29.46 | 32.35 | 35.51 |
| Infectious Diseases | 12.73 | 13.40 | 14.09 | 14.81 | 15.54 | 16.29 | 17.06 | 17.84 | 18.62 | 19.41 |
| Others | 12.73 | 13.88 | 15.14 | 16.52 | 18.01 | 19.65 | 21.43 | 23.37 | 25.49 | 27.79 |
Central Nervous System Therapeutic Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 50.92 | 54.76 | 58.89 | 63.33 | 68.09 | 73.20 | 78.69 | 84.58 | 90.90 | 97.68 |
| Asia Pacific | 38.19 | 42.18 | 46.57 | 51.41 | 56.74 | 62.61 | 69.06 | 76.17 | 83.98 | 92.58 |
| Europe | 25.46 | 27.59 | 29.90 | 32.40 | 35.11 | 38.05 | 41.23 | 44.68 | 48.41 | 52.46 |
| LAMEA | 12.73 | 13.76 | 14.87 | 16.08 | 17.38 | 18.78 | 20.30 | 21.94 | 23.71 | 25.63 |
Central Nervous System Therapeutic Market Size to Lead USD 285.72 Billion by 2034
The central nervous system therapeutic market size accounted for USD 127.29 billion in 2025 and is predicted to touch around USD 285.72 billion by 2034 at a CAGR of 8.64%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
